Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q3 2014 · 10-Q
Revenue$1.86M$1.86M+1,036.5% vs Q3 2013 Net Income-$482.13K-$482.13KN/M vs Q3 2013 EPS Diluted-$0.01-$0.01N/M vs Q3 2013 Gross Profit$1,122,419+875.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,424,547N/M Free Cash Flowderived-$4,558,438N/M Margins · derivedGross margin60.3%−10.0 pt vs Q3 2013
Operating margin-26.4%+386.8 pt vs Q3 2013
Net margin-25.9%+469.5 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 14, 2014 · 45 d after period end